J&J restructures pharma manufacturing footprint at cost of up to $750M

July 15, 2026 12:48 PM EDT PharmaManufacturing J&J re­struc­tures phar­ma man­u­fac­tur­ing foot­print at cost of up to $750M Anna Brown News Reporter John­son & John­son is an­tic­i­pat­ing as much as $750 mil­lion in costs to re­struc­ture its phar­ma­ceu­ti­cal sup­ply chain and ex­it fac­to­ries, moves that are com­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER